These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15831847)

  • 1. The influence of big pharma.
    Ferner RE
    BMJ; 2005 Apr; 330(7496):855-6. PubMed ID: 15831847
    [No Abstract]   [Full Text] [Related]  

  • 2. How a marriage with big pharma ended in divorce.
    Arie S
    BMJ; 2013 Oct; 347():f6062. PubMed ID: 24103763
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicine and public affairs: Kennedy urges further pharmaceutical regulation.
    Greenberg DS
    N Engl J Med; 1974 May; 290(21):1211-2. PubMed ID: 4824024
    [No Abstract]   [Full Text] [Related]  

  • 4. Insiders say NICE is being encouraged to be more favourable to industry.
    Cohen D
    BMJ; 2014 Oct; 349():g6387. PubMed ID: 25336090
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicines regulation and the pharmaceutical industry.
    Breckenridge A; Woods K
    BMJ; 2005 Oct; 331(7520):834-6. PubMed ID: 16210285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big pharma under the spotlight.
    Farham B
    S Afr Med J; 2013 May; 103(6):352. PubMed ID: 23725968
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicines Commission.
    Br Med J; 1968 Feb; 1(5589):396-7. PubMed ID: 5635930
    [No Abstract]   [Full Text] [Related]  

  • 8. Andrew Witty: the acceptable face of big pharma? Interviewed by Rebecca Coombes.
    Witty A
    BMJ; 2013 Mar; 346():f1458. PubMed ID: 23468295
    [No Abstract]   [Full Text] [Related]  

  • 9. An integrated national pharmaceutical policy for the United Kingdom?
    Walley T; Earl-Slater A; Haycox A; Bagust A
    BMJ; 2000 Dec; 321(7275):1523-6. PubMed ID: 11118184
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDS drugs. Brazil, Thailand override big pharma patents.
    Cohen J
    Science; 2007 May; 316(5826):816. PubMed ID: 17495145
    [No Abstract]   [Full Text] [Related]  

  • 11. Public sector funding in the UK.
    Owen DA
    Nat Biotechnol; 1998 May; 16 Suppl():64. PubMed ID: 9591278
    [No Abstract]   [Full Text] [Related]  

  • 12. Big pharma and the UK Government.
    Collier J
    Lancet; 2006 Jan; 367(9505):97-8. PubMed ID: 16413862
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs and the relationships between university, industry and legislation.
    Calin A
    Drugs Exp Clin Res; 1987; 13(11):685-7. PubMed ID: 3443044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Technology Assessment. NICE goes global.
    Hawkes N
    BMJ; 2009 Jan; 338():b103. PubMed ID: 19176677
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharma to boycott UK?
    Mitchell P
    Nat Biotechnol; 2008 Aug; 26(8):847. PubMed ID: 18688226
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology in the United Kingdom.
    Smith RN
    Clin Pharmacol Ther; 1974 Sep; 16(3):605-15. PubMed ID: 4412474
    [No Abstract]   [Full Text] [Related]  

  • 17. New terms for the pharmaceutical price regulation scheme.
    Drug Ther Bull; 1993 Dec; 31(26):103-4. PubMed ID: 8306850
    [No Abstract]   [Full Text] [Related]  

  • 18. MPs' report criticises influence of drugs industry on GP prescribing.
    Kmietowicz Z
    BMJ; 2008 Jan; 336(7636):111. PubMed ID: 18202047
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the relationship between pharma and medical education on the rocks?
    Moynihan R
    BMJ; 2008 Aug; 337():a925. PubMed ID: 18703653
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug regulation: a sometimes unhealthy coalition.
    Iheanacho I
    BMJ; 2010 May; 340():c2613. PubMed ID: 20484352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.